Transformation of myelodysplastic syndrome to mixed phenotype acute leukaemia

Transformation of myelodysplastic syndrome to mixed phenotype acute leukaemia

Bibliographic Details
Main Authors:	Louis Do, John Giannoutsos
Format:	Article
Language:	English
Published:	Wiley 2020-07-01
Series:	eJHaem
Online Access:	https://doi.org/10.1002/jha2.59

Similar Items

Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia
by: R Edlin, et al.
Published: (2010-05-01)

Our treatment experience with azacytidine in patients with acute myeloid leukaemia, chronic myelomonocytic leukaemia and myelodysplastic syndrome
by: Peter Černelč, et al.
Published: (2012-12-01)

Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia.
by: Boultwood, J, et al.
Published: (2004)

Serial monitoring of circulating tumour DNA on clinical outcome in myelodysplastic syndromes and acute myeloid leukaemia
by: Xinping Zhou, et al.
Published: (2023-07-01)

Frequent Mutation of the Polycomb-Associated Gene ASXL1 in the Myelodysplastic Syndromes and in Acute Myeloid Leukaemia
by: Boultwood, J, et al.
Published: (2009)

Erythroblastic islands: A fertile ground for CD47 expression in myelodysplastic syndrome and acute erythroid leukaemia
by: Sophie Le Grand, et al.
Published: (2024-02-01)

HAPLOIDENTICAL TRANSPLANT WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR ACUTE MYELOID LEUKAEMIA AND MYELODYSPLASTIC SYNDROMES PATIENTS: THE ROLE OF PREVIOUS LINES OF THERAPY.
by: Daniele Avenoso, et al.
Published: (2024-01-01)

Superior sagittal sinus thrombosis in the course of mixed phenotype acute leukaemia treated with acute lymphoblastic leukaemia-like therapy—a case report
by: Wojciech Lizurej, et al.
Published: (2023-11-01)

Effect of invasive aspergillosis on risk for different causes of death in older patients with acute myeloid leukaemia or high-risk myelodysplastic syndrome
by: Rebecca van Grootveld, et al.
Published: (2023-02-01)

Acute Myleoid Leukaemia t(8;21)- A Close Differential Diagnosis to Myelodysplastic Syndrome with Excess Blasts-2: A Case Report
by: Bhusari Harveen, et al.
Published: (2022-07-01)

PHASE 3B STUDY DESIGN: COMPARING TREATMENT PREFERENCE BETWEEN ORAL DECITABINE/CEDAZURIDINE AND AZACITIDINE IN PATIENTS WITH MYELODYSPLASTIC SYNDROME, LOW-BLAST ACUTE MYELOID LEUKAEMIA, OR CHRONIC MYELOMONOCYTIC LEUKAEMIA
by: A. Enjeti, et al.
Published: (2024-01-01)

Acute myeloid leukemia cells and MSC-derived exosomes inhibiting transformation in myelodysplastic syndrome
by: Xiaoli Liu, et al.
Published: (2023-06-01)

Higher RUNX1 expression levels are associated with worse overall and leukaemia‐free survival in myelodysplastic syndrome patients
by: Yu‐Hung Wang, et al.
Published: (2022-11-01)

P1288: UNMANIPULATED PERIPHERAL HAPLOIDENTICAL HAEMATOPOIETIC STEM CELL TRANSPLANT IS AN EFFECTIVE CONSOLIDATIVE STRATEGY FOR HIGH-RISK ACUTE MYELOID LEUKAEMIA AND MYELODYSPLASTIC SYNDROME
by: Fabio Serpenti, et al.
Published: (2023-08-01)

The role and impact of Del(5q) and TP53 mutations on haematopoietic stem and progenitor cells during the progression of Myelodysplastic Syndrome to Acute Myeloid Leukaemia
by: Doolittle, H
Published: (2017)

Whole-exome sequencing in del(5q) myelodysplastic syndromes in transformation to acute myeloid leukemia.
by: Pellagatti, A, et al.
Published: (2014)

Whole-exome sequencing in del(5q) myelodysplastic syndromes in transformation to acute myeloid leukemia
by: Pellagatti, A, et al.
Published: (2014)

Laboratory diagnostics stages of myelodysplastic syndrome transformation into acute erythroid leukemia (clinical case report)
by: I. E. Volgina
Published: (2022-01-01)

Myelodysplastic syndromes
by: Johanna Ungerstedt, (Coordinating Author)
Published: (2019-06-01)

Myelodysplastic syndromes
by: Eva Hellström Lindberg
Published: (2018-06-01)

DHX9-mediated pathway contributes to the malignant phenotype of myelodysplastic syndromes
by: Nanfang Huang, et al.
Published: (2023-06-01)

Phenotypic and functional changes of NK cells in patients with myelodysplastic syndrome and acute myeloid leukemia treated with hypomethylating drugs
by: D. I. Zhigarev, et al.
Published: (2021-05-01)

Autophagy in the pathogenesis of myelodysplastic syndrome and acute myeloid leukemia.
by: Watson, A, et al.
Published: (2011)

Immune Therapies for Myelodysplastic Syndromes and Acute Myeloid Leukemia
by: Sargam Kapoor, et al.
Published: (2021-10-01)

Improved outcome of acute myeloid leukaemia in Down's syndrome.
by: Craze, J, et al.
Published: (1999)

Immune Checkpoint Inhibition in Acute Myeloid Leukemia and Myelodysplastic Syndromes
by: Yasmin Abaza, et al.
Published: (2022-07-01)

Isocitrate Dehydrogenase Mutations in Myelodysplastic Syndromes and in Acute Myeloid Leukemias
by: Ugo Testa, et al.
Published: (2020-08-01)

TP53 Alterations in Myelodysplastic Syndromes and Acute Myeloid Leukemia
by: Ramy Rahmé, et al.
Published: (2023-04-01)

Clonality in the myelodysplastic syndromes.
by: Boultwood, J, et al.
Published: (2001)

Angiogenesis in myelodysplastic syndromes.
by: Pruneri, G, et al.
Published: (1999)

Genetics of Myelodysplastic Syndromes
by: Caner Saygin, et al.
Published: (2021-07-01)

Myelodysplastic Syndromes and Metabolism
by: Ekaterina Balaian, et al.
Published: (2021-10-01)

Pathophysiology of Myelodysplastic Syndromes
by: Michaela Fontenay, et al.
Published: (2021-07-01)

P574: DIAGNOSIS AND TREATMENT OF T/MYELOID MIXED PHENOTYPE ACUTE LEUKAEMIA (T/M-MPAL)- A UK SINGLE CENTRE EXPERIENCE
by: Enas Abusalim, et al.
Published: (2023-08-01)

P1677: DEFINING KEY QUALITY OF LIFE METRICS IN ACUTE MYELOID LEUKAEMIA AND HIGH RISK MYELODYSPLASTIC SYNDROME PATIENTS ENROLLED IN LARGE-SCALE UK NCRI AML TRIALS
by: Pramila Krishnamurthy, et al.
Published: (2023-08-01)

Predicting leukemic transformation in myelodysplastic syndrome using a transcriptomic signature
by: Chao Guo, et al.
Published: (2023-10-01)

High Expression of ENO1 and Low Levels of Circulating Anti-ENO1 Autoantibodies in Patients with Myelodysplastic Neoplasms and Acute Myeloid Leukaemia
by: Lisa F. Lincz, et al.
Published: (2024-02-01)

Secondary acute myeloid leukaemia in children treated for acute lymphoblastic leukaemia.
by: Eden, O, et al.
Published: (1998)

Splicing factor gene mutations in the myelodysplastic syndromes: impact on disease phenotype and therapeutic applications.
by: Pellagatti, A, et al.
Published: (2016)

Navigating the contested borders between myelodysplastic syndrome and acute myeloid leukemia
by: Alexander J. Ambinder, et al.
Published: (2022-10-01)